Prevalence of Hypomagnesaemia among Obese Type 2 Diabetic Patients Attending the National Center for Diabetes, Endocrinology and Genetics (NCDEG)

Authors Information
Article Notes and Dates
To Cite : Hyassat D, Al Sitri E, Batieha A, EL-Khateeb M, Ajlouni K. et al. Prevalence of Hypomagnesaemia among Obese Type 2 Diabetic Patients Attending the National Center for Diabetes, Endocrinology and Genetics (NCDEG), Int J Endocrinol Metab. 2014 ;12(3):e17796. doi: 10.5812/ijem.17796.
Copyright: Copyright © 2014, International Journal of Endocrinology and Metabolism. .
Abstract
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Pleschchister AJ. Magnesium. Clin. Chem. 1958; 4: 429-33
  • 2. Fawcett WJ, Haxby EJ, Male DA. Magnesium: physiology and pharmacology. BJA. 1999; 83(2): 302-20[DOI]
  • 3. Saris NL, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A. Managment of Hypomagnesaemia. Clin Chim. 2000; 294(1-2): 1-26[DOI]
  • 4. Walker GM. Magnesium and cell cycle control: an update. Magnesium. 1986; 5(1): 9-23[PubMed]
  • 5. Laurant P, Touyz RM. Physiological and pathophysiological role of magnesium in the cardiovascular system. IJH. 2000; 18(9): 1177-91[DOI]
  • 6. Rude RK. Magnesium deficiency and diabetes mellitus. Causes and effects. Postgrad Med. 1992; 92(5): 217-9[PubMed]
  • 7. Ghasemi A, Zahediasl S, Syedmoradi L, Azizi F. Low serum magnesium levels in elderly subjects with metabolic syndrome. Biol Trace Elem Res. 2010; 136(1): 18-25[DOI][PubMed]
  • 8. Barbagallo M. Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. MOL ASPECTS MED J. 2003; 24(1-3): 39-52[DOI]
  • 9. Tosiello L. Hypomagnesemia and Diabetes Mellitus. Intern Med. 1996; 156(11): 1143[DOI]
  • 10. Magnesium supplementation in the treatment of diabetes. American Diabetes Association. Diabetes Care. 1992; 15(8): 1065-7[PubMed]
  • 11. Batieha A, Khader Y, Jaddou H, Hyassat D, Batieha Z, Khateeb M, et al. Vitamin D status in Jordan: dress style and gender discrepancies Ann Nutr Metab. 2011; 58(1)[PubMed]
  • 12. Physical status: the use and interpretation of anthropometry : report of WHO expert committee 1995;
  • 13. Khader YS, Batieha A, Jaddou H, Batieha Z, El-Khateeb M, Ajlouni K. Anthropometric cutoff values for detecting metabolic abnormalities in Jordanian adults. Diabetes Metab Syndr Obes. 2010; 3: 395-402[DOI][PubMed]
  • 14. Standards of medical care in diabetes 2011. D C. 2011; 30(1)
  • 15. American Diabetes Association . Dyslipidemia management in adult with diabetes. D C. 2004; 27(1): 68-71
  • 16. Syedmoradi L, Ghasemi A, Zahediasl S, Azizi F. Prevalence of hypo- and hypermagnesemia in an Iranian urban population. Ann Hum Biol. 2011; 38(2): 150-5[DOI][PubMed]
  • 17. Seyoum B, Siraj ES, Saenz C, Abdulkadir J. Hypomagnesemia in Ethiopians with diabetes mellitus. Ethn Dis. 2008; 18(2): 147-51[PubMed]
  • 18. Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Arch Intern Med. 1999; 159(18): 2151-9[PubMed]
  • 19. Crook M, Couchman S, Tutt P, Amiel S, Swaminathan R. Erythrocyte, plasma total, ultrafiltrable and platelet magnesium in type 2 (non-insulin dependent) diabetes mellitus. Diabetes Res. 1994; 27(2): 73-9[PubMed]
  • 20. Levin GE, Mather HM, Pilkington TR. Tissue magnesium status in diabetes mellitus. Diabetologia. 1981; 21(2): 131-4[PubMed]
  • 21. Ascaso J. Abdominal obesity, insulin resistance, and metabolic syndrome in a southern European population. ejinme. 2003; 14(2): 101-6[DOI]
  • 22. Sheehan JP. Magnesium deficiency and diabetes mellitus. Magnes Trace Elem. 1991; 10(2-4): 215-9[PubMed]
  • 23. Shaikh MK, Devrajani BR, Soomro AA, Ali Shah SZ, Devrajani T, Das T. Hypomagnesaemia in Patients with Diabetes mellitus. World Appl Sci J. 2011; 12(10): 1803-6
  • 24. Fujii S, Takemura T, Wada M, Akai T, Okuda K. magnasium levels in plasma,erythrocytes and urine inpatients with diabetes mellitus. Hourm Metab. Res. 1982; 14: 161-2
  • 25. DeValk HW, Hardus PLLJ, Van Rijn HJM, Erkelens DW. Plasma magnesium concentration and progression of retinopathy. Diab. Care. 1999; 22: 864-5[DOI]
  • 26. McNair P, Christiansen C, Madsbad S, Lauritzen E, Faber O, Binder C, et al. Hypomagnesemia, a risk factor in diabetic retinopathy. Diabetes. 1978; 27(11): 1075-7[PubMed]
  • 27. Resnick LM, Gupta RK, Bhargava KK, Gruenspan H, Alderman MH, Laragh JH. Cellular ions in hypertension, diabetes, and obesity. A nuclear magnetic resonance spectroscopic study. Hypertension. 1991; 17(6 Pt 2): 951-7[PubMed]
  • 28. Haenni A, Ohrvall M, Lithell H. Serum magnesium status during lipid-lowering drug treatment in non-insulin-dependent diabetic patients. Metabolism. 2001; 50(10): 1147-51[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

International Journal of Endocrinology and Metabolism accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check